ASH ANNUAL MEETING, DECEMBER 7-10, 2024
🚀 Exciting News! 🚀
Join us at the 66th ASH Annual Meeting in San Diego, California, where Sara Majocchi will present our latest research on innovative approaches for treating multiple myeloma. 🎗️
🌟 Poster #2796: "Generation of FcRH5xCD28 Bispecific Antibodies Synergizing with T-Cell Engagers for Enhanced Multiple Myeloma Treatment"
📅 Date: Sunday, December 8, 2024
🕕 Time: 6:00 PM - 8:00 PM
Discover how our work is pushing the boundaries of T-cell engagement and bispecific antibodies to offer new hope for multiple myeloma patients. This is a great opportunity to explore how FcRH5xCD28 bispecific antibodies are designed to synergize for enhanced therapeutic impact.
Don’t miss this chance to connect and dive into groundbreaking science!
#ASH2024 #MultipleMyeloma #Immunotherapy #BispecificAntibodies #CancerResearch #TCellEngagers